What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2023-08-14 compared with 2023-05-22 · 38 added, 7 removed, 29 unchanged (61% of the section changed)

1 unchanged sentence

Not applicable.

The exhibits filed as part of this Quarterly Report on Form 10-Q are

listed in the exhibit index included herewith and are incorporated by reference herein.

The exhibits filed as part of

this Quarterly Report on Form 10-Q are listed in the exhibit index included herewith and are incorporated by reference herein .

EXHIBIT INDEX

Certificate of Designation of Preferences, Rights and Limitations of the Series B Convertible Preferred Stock (incorporated by reference to Exhibit 3.2 of the Registrant’s Current Report on Form 8-K filed with the SEC on February 13, 2023).

Sales Agreement, dated June 16, 2023, by and between Avalon GloboCare Corp.

and Roth Capital Partners, LLC.

(incorporated by reference to Exhibit 1.1 of the Registrant’s Current Report on Form 8-K filed with the SEC on June 16, 2023).

Avalon GloboCare Corp.

2020 Incentive Stock Plan (incorporated by reference to Exhibit 4.1 of the Registrant’s Report on Form S-8 filed with the Securities and Exchange Commission on December 8, 2020).

Director Agreement by and Between Avalon GloboCare Corp.

and Lourdes Felix dated January 9, 2023 (incorporated by reference to Exhibit 10.1 of the Registrants Current Report on Form 8-K filed with the SEC on January 11, 2023).

Second Amended and Restated Limited Company Agreement, dated February 9, 2023, by and among Laboratory Services MSO, LLC, SCBC Holdings LLC, the Zoe Family Trust, Bryan Cox, Sarah Cox and the members named therein (incorporated by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K filed on February 13, 2023).

Securities Purchase Agreement, dated May 23, 2023, between Avalon GloboCare Corp.

and Mast Hill Fund, L.P (incorporated by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K filed with the SEC on May 26, 2023).

Security Agreement, dated May 23, 2023, by and among Avalon GloboCare Corp., Avalon Healthcare System Inc., Avalon Laboratory Services, Inc., Avalon RT 9 Properties, LLC, Avactis Biosciences, Inc., Laboratory Services MSO, LLC, Genexosome Technologies Inc., International Exosome Association LLC and Mast Hill Fund, L.P.

(incorporated by reference to Exhibit 10.2 of the Registrant’s Current Report on Form 8-K filed with the SEC on May 26, 2023).

Senior Secured Promissory Note, dated May 23, 2023, between Avalon Globocare Corp.

and Mast Hill Fund, L.P.

(incorporated by reference to Exhibit 10.3 of the Registrant’s Current Report on Form 8-K filed with the SEC on May 26, 2023).

First Warrant, dated May 23, 2023, by and between Avalon GloboCare Corp.

and Mast Hill Fund, L.P.

(incorporated by reference to Exhibit 10.4 of the Registrant’s Current Report on Form 8-K filed with the SEC on May 26, 2023).

Second Warrant, dated May 23, 2023, by and between Avalon GloboCare Corp.

and Mast Hill Fund, L.P.

(incorporated by reference to Exhibit 10.5 of the Registrant’s Current Report on Form 8-K filed with the SEC on May 26, 2023).

Form of Balloon Mortgage Note (incorporated by reference to Exhibit 10.6 of the Registrant’s Current Report on Form 8-K filed with the SEC on May 26, 2023).

Form of Second Mortgage and Security Agreement (incorporated by reference to Exhibit 10.7 of the Registrant’s Current Report on Form 8-K filed with the SEC on May 26, 2023).

Form of Guaranty (incorporated by reference to Exhibit 10.8 of the Registrant’s Current Report on Form 8-K filed with the SEC on May 26, 2023).

Form of Hazardous Material Guaranty and Indemnification Agreement (incorporated by reference to Exhibit 10.9 of the Registrant’s Current Report on Form 8-K filed with the SEC on May 26, 2023).

Securities Purchase Agreement, dated July 6, 2023, by and between Avalon Globocare Corp.

and Firstfire Global Opportunities, LLC.

(incorporated by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K filed with the SEC on July 10, 2023).

Security Agreement, dated July 6, 2023, by and among Avalon GloboCare Corp., Avalon Healthcare System Inc., Avalon Laboratory Services, Inc., Avalon RT 9 Properties, LLC, Avactis Biosciences, Inc., Laboratory Services MSO, LLC, Genexosome Technologies Inc., International Exosome Association LLC and Firstfire Global Opportunities, LLC.

(incorporated by reference to Exhibit 10.2 of the Registrant’s Current Report on Form 8-K filed with the SEC on July 10, 2023).

Senior Secured Promissory Note, dated July 6, 2023, by and between Avalon GloboCare Corp.

and Firstfire Global Opportunities, LLC.

(incorporated by reference to Exhibit 10.3 of the Registrant’s Current Report on Form 8-K filed with the SEC on July 10, 2023).

First Warrant dated July 6, 2023, by and between Avalon GloboCare Corp.

and Firstfire Global Opportunities, LLC.

(incorporated by reference to Exhibit 10.4 of the Registrant’s Current Report on Form 8-K filed with the SEC on July 10, 2023).

Second Warrant, dated July 6, 2023, by and between Avalon Globocare Corp.

and Firstfire Global Opportunities, LLC.

(incorporated by reference to Exhibit 10.5 of the Registrant’s Current Report on Form 8-K filed with the SEC on July 10, 2023).

Certification of the Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

13 unchanged sentences

** Furnished herewith.

contract or compensatory plan or arrangement.

Pursuant to the requirements of the Securities

1 unchanged sentence

AVALON GLOBOCARE CORP.

August 14, 2023

Chief Executive Officer

1 unchanged sentence

/s/ Luisa Ingargiola

August 14, 2023

Luisa Ingargiola

2 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information